Michael D. Bookman - 29 Jul 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
General Counsel and Secretary
Signature
By: /s/ Michael D. Bookman
Issuer symbol
IMRX
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
4
Filing time
30 Jul 2021, 16:29:18 UTC
Next filing
04 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 -101,116 -50% $0.000000 101,116 29 Jul 2021 Class A Common Stock 101,116 $15.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on July 15, 2022 and then in equal monthly installments over the subsequent three years, subject to Mr. Bookman's continued employment through each applicable vesting date.